Grant number: 107526 | Funding period: 2022 - 2027
Active
LT Ursich, AJ Pearl, XJ Maddern, AJ Lawrence, LC Walker
2026-05-01
Alcohol use is a leading risk factor for premature mortality, yet effective pharmacotherapies remain limited. Neurosteroids, such ..
SP Vaidya, DL Spark, LC Walker, P Pinares-Garcia, RG Anversa, AJ Lawrence
2026-03-26
AbstractThe mesopontine tegmentum (MPT), consisting of the pedunculopontine tegmentum (PPTg) and laterodorsal tegmentum (LDTg) reg..
Roberta Goncalves Anversa, Kathleen S-L Teng, Aida Viden, Sarah S Ch'ng, Brandon K Richards, Tobian Catsburg, Amy J Pearl, Leigh C Walker, Christina J Perry, Craig M Smith, Andrew J Lawrence
2026-03-17
The overconsumption of sodium contributes to a wide range of detrimental health conditions. Thus, it is imperative to gain a bette..
JBB Garfield, B Rowland, SK Liu, H Piercy, Y Bonomo, D Whelan, V Manning
2026-01-01
Background and aims: Several randomised controlled trials (RCTs) have demonstrated that delivering approach bias modification (ApB..
BJ Cooley, CV Occelli Hanbury-Brown, EA Choi, WA Heller, AW Lim, AJ Lawrence, PS Haber, GP McNally, EZ Millan
Fibroblast growth factor 21 (FGF21) is a liver-derived hormone known to suppress alcohol consumption in mice and non-human primate..
KL Huckstep, B Newton, G Bailey, A Charlton, AJ Pearl, XJ Maddern, RM Brown, GP McNally, DI Lubman, S Arunogiri, KC Morley, EJ Campbell, AJ Lawrence, LC Walker
Comorbidity between post-traumatic stress disorder (PTSD) and alcohol use is common and mutually-reinforcing, yet there are no pha..
R Anversa, L Tran, A Bolinger, J Zhou, K Cunningham, A Lawrence, E Campbell
2025-11-01
Alcohol misuse remains a leading cause of preventable death worldwide, prompting research into novel pharmacotherapies for alcohol..
RG Anversa, G Goldstein, I Syed, H Dempsey, A Pearl, XJ Maddern, B Newton, RM Brown, FM Reed, AJ Lawrence, LC Walker
2025-09-01
Background: The decision about whether to approach or avoid a reward while under threat requires balancing competing demands. Sex-..
SP Vaidya, RG Anversa, P Pinares-Garcia, LC Walker, N Pracejus, CA Reid, AJ Lawrence
2025-06-01
Globally, around 400 million people live with an alcohol use disorder (AUD), yet current treatments available are suboptimal at a ..
SJ Farias Cardozo, AJ Lawrence, RG Anversa
2025-02-01
Electronic cigarette use among adolescents is a growing concern, not only due to the high incidence of co-use with other substance..
M Sihag, M Varma, R Bhandari, AJ Lawrence
2025-01-16
Substance use disorders (SUDs) pose a significant global health challenge, with relapse being a major obstacle in achieving succes..
G Dali, W Logge, HR Kranzler, T Hurzeler, H Gallagher, PS Haber, KC Morley
2025-01-01
Topiramate has been found to be effective in reducing alcohol use and may also attenuate anxiety severity in patients with alcohol..
AJ Pearl, XJ Maddern, P Pinares-Garcia, LT Ursich, RG Anversa, A Shesham, RM Brown, FM Reed, WJ Giardino, AJ Lawrence, LC Walker
Risky drinking rates are rising, particularly in women, yet sex as a biological variable has only recently gained traction. The ce..
LC Walker, KL Huckstep, HC Becker, CJ Langmead, AJ Lawrence
2024-11-01
Emerging evidence suggests muscarinic acetylcholine receptors represent novel targets to treat alcohol use disorder. In this revie..
Ethan Murphy, Govinda Poudel, Saampras Ganesan, Chao Suo, Victoria Manning, Emillie Beyer, Adam Clemente, Bradford A Moffat, Andrew Zalesky, Valentina Lorenzetti
2024-10-01
INTRODUCTION: Real-time functional magnetic resonance based-neurofeedback (fMRI-neurofeedback) is a neuromodulation tool where ind..
XJ Maddern, LT Ursich, G Bailey, A Pearl, RG Anversa, AJ Lawrence, LC Walker
2024-09-01
Risky alcohol use and alcohol use disorders (AUD) are a rising problem in women, yet a major disparity in our understanding of wha..
XJ Maddern, LC Walker, RG Anversa, AJ Lawrence, EJ Campbell
Persistent substance use despite negative consequences is a key facet of substance use disorder. The last decade has seen the prec..
SJ McDougall, ZY Ong, R Heller, A Horton, KK Thek, EA Choi, GP McNally, AJ Lawrence
The nucleus of the solitary tract (NTS) receives direct viscerosensory vagal afferent input that drives autonomic reflexes, neuroe..
RG Anversa, ML Barron, LC Walker, AJ Lawrence
2024-08-01
G protein-coupled receptors (GPCRs) are the largest group of membrane receptors in the central nervous system and one of the key p..
Erin J Campbell, Yvonne Bonomo, Lisa Collins, Amanda Norman, Helen O'Neill, Amanda Streitberg, Kate Galloway, Andrew Kyoong, Andrew Perkins, Adam Pastor, Andrew J Lawrence
2024-05-01
KEY CLINICAL MESSAGE: This case suggests using dual orexin receptor antagonists to treat alcohol use disorder and comorbid sleep d..
Roberta Goncalves Anversa, Xavier J Maddern, Andrew J Lawrence, Leigh C Walker
2024-03-01
Neuropeptides and G protein-coupled receptors (GPCRs) have long been, and continue to be, one of the most popular target classes f..
XJ Maddern, B Letherby, SS Ch’ng, A Pearl, A Gogos, AJ Lawrence, LC Walker
2024-02-01
The neuropeptide cocaine- and amphetamine-regulated transcript (CART) has been implicated in alcohol consumption and reward behavi..
Xavier J Maddern, Andrew J Lawrence, Erin J Campbell
Maintaining abstinence and preventing relapse are key to the successful recovery from alcohol use disorder. There are two main way..
S Jin, EJ Campbell, CK Ip, S Layfield, RAD Bathgate, H Herzog, AJ Lawrence
2023-08-01
The nucleus accumbens shell is a critical node in reward circuitry, encoding environments associated with reward. Long-range input..
GP McNally, P Jean-Richard-dit-Bressel, EZ Millan, AJ Lawrence
2023-06-01
The persistence of drug taking despite its adverse consequences plays a central role in the presentation, diagnosis, and impacts o..
XJ Maddern, LC Walker, EJ Campbell, S Arunogiri, PS Haber, K Morley, V Manning, EZ Millan, GP McNally, DI Lubman, AJ Lawrence
2022-11-01
Despite decades of research in the field of addiction, relapse rates for substance use disorders remain high. Consequently, there ..